Cargando…
Auranofin Is Highly Efficacious against Toxoplasma gondii In Vitro and in an In Vivo Experimental Model of Acute Toxoplasmosis
BACKGROUND: The mainstay of toxoplasmosis treatment targets the folate biosynthetic pathways and has not changed for the last 50 years. The activity of these chemotherapeutic agents is restricted to one lifecycle stage of Toxoplasma gondii, they have significant toxicity, and the impending threat of...
Autores principales: | Andrade, Rosa M., Chaparro, Juan D., Capparelli, Edmund, Reed, Sharon L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4117455/ https://www.ncbi.nlm.nih.gov/pubmed/25079790 http://dx.doi.org/10.1371/journal.pntd.0002973 |
Ejemplares similares
-
Diagnosis of toxoplasmosis and typing of Toxoplasma gondii
por: Liu, Quan, et al.
Publicado: (2015) -
The ethanolic extract of the fungus Trichoderma stromaticum decreases the Toxoplasma gondii replication in vitro and ameliorates the experimental toxoplasmosis in vivo
por: Nascimento, Layane Alencar Costa, et al.
Publicado: (2022) -
Auranofin Resistance in Toxoplasma gondii Decreases the Accumulation of Reactive Oxygen Species but Does Not Target Parasite Thioredoxin Reductase
por: Ma, Christopher I., et al.
Publicado: (2021) -
Experimental Porcine Toxoplasma gondii Infection as a Representative Model for Human Toxoplasmosis
por: Nau, Julia, et al.
Publicado: (2017) -
Toxoplasma gondii cathepsin proteases are undeveloped prominent vaccine antigens against toxoplasmosis
por: Zhao, Guanghui, et al.
Publicado: (2013)